NEWS & INSIGHTS

In the last five years, 83 novel oncology substances have launched – oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.

Join a discussion with PRECISIONvalue’s Access Experience Team (AET), comprised of former payers, to hear their insights on current trends in oncology payer management, payer response, payer management strategies, and the evolution of value-based care.

Moderated by PRECISIONvalue VP and Access Experience Team Director Ryan Cox, this one hour webinar will feature two of Precision’s senior oncology subject matter experts, Janet Serluco and Jennifer Williams.

Attendees of this webinar will come away with an understanding of:

• The current drivers in oncology spend, including biosimilars and next generation biotherapeutics
• How the product pipeline reinforces trend continuation
• New management tools being implemented
• The future of value-based oncology care

In addition to the expert conversation, a live Q&A will conclude the webinar.

REGISTER HERE!

Doctors say it to sales reps all the time: “I like your drug and want to write it, but I can’t.” Where does your rep go from there?

New research indicates that 50% of an HCPs’ prescribing decision is based on their perception of accessibility. (But perception and reality can be two vastly different things.)

Marketers can’t change how accessible their products are, but they can change how HCPs view their brands’ accessibility on healthcare plans. In this webinar, you’ll hear about:

• The most threatening market access challenges pharma brand leaders face today
• Real-world stories of how top brands overcome these challenges and grow market share
• Tangible tactics you can quickly implement to start making pull-through headway fast

This solution-focused, truth-packed session is a great fit for market access marketers, brand marketers and sales leaders who are interested in making their brands’ market access a top advantage over the competition.

WATCH ON DEMAND HERE

In this upcoming one-hour webinar, PRECISONadvisors Vice President Richard Macaulay will moderate a lively discussion with our panel of European payer experts as they examine the next generation of gene therapies, and weigh considerations for policy makers as well as manufacturers.

Issues to be discussed by the panel will include:

-Gene therapy treatments for diseases that take years to develop (e.g. Huntington’s Disease, Prion diseases)
-Gene Therapies to prevent development of diseases in genetically susceptible individuals (e.g. early-onset familial Alzheimer’s disease)
-Gene therapies to be used in utero (with the potential to treat lethal and morbid perinatal diseases before birth, as well as potentially using existing gene therapies much earlier in disease progression).

The discussion will conclude with a live Q&A.

WATCH ON DEMAND HERE

Want to boost sales with HCP specific market access pull-through messaging tailored to your patient population? Discover how Access Genius can drive radical brand prescription growth and amplify sales with a 4:1 proven ROI.

Download the Infographic here to learn more!